Report - Zelira Therapeutics - 191124 Zelira Merger AGM …...Market Cap (USD) Revenue (2018) Market Cap to Revenue Ratio Product & Development Status GW Pharmaceuticals $3.3B $26.6M 124.1x

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form